Search for: "Mutual Pharmaceutical Company, Inc."
Results 81 - 100
of 145
Sorted by Relevance
|
Sort by Date
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA … [read post]
30 Dec 2013, 5:25 am
Mutual Pharmaceutical Co. v. [read post]
1 Apr 2016, 3:02 am
EMD Serono, Inc., 2016 WL 1086028 (N.D. [read post]
5 Mar 2015, 5:52 am
Mylan Pharmaceutical, Inc., ___ F. [read post]
16 Jan 2021, 10:57 pm
Companies use letters of intent as a versatile tool to meet the needs of their business transactions. [read post]
28 Nov 2016, 12:31 pm
In addition, many are predicting a boom for M&A in specific industries, such as pharmaceuticals. [read post]
24 Aug 2011, 5:29 pm
Author Robert Elliott, executive vice president, Amaxx Risks Solutions, Inc. has worked successfully for 20 years with many industries to reduce Workers Compensation costs, including airlines, healthcare, printing/publishing, pharmaceuticals, retail, hospitality and manufacturing. [read post]
29 Dec 2010, 2:57 am
Ferring Pharmaceuticals, Inc et al. [read post]
5 Sep 2013, 12:24 pm
Ortho-McNeil-Janssen Pharmaceuticals, Inc., 808 F. [read post]
21 Jan 2022, 2:17 pm
Hawbaker, Inc. [read post]
21 Jan 2022, 2:17 pm
Hawbaker, Inc. [read post]
20 Jul 2011, 4:04 am
: Supreme Court hearing Human Genome Sciences Inc v Eli Lilly and Company (IPKat) Nexium (Esomeprazole) – UK: EWHC: Ranbaxy wins declaration of non-infringement: Ranbaxy v AstraZeneca (IPKat) Olanzapine – Spain: Supreme Court hands down landmark judgment on doctrine of equivalents and TRIPS (Kluwer Patent Blog) OxyContin (Oxycodone) – US: Purdue files patent infringement suit against Sandoz in response to Para IV certification (Patent Docs) Prevacid (Lansoprazole)… [read post]
16 Jun 2013, 3:49 pm
Mutual Pharmaceutical Co. v. [read post]
26 Jul 2012, 10:33 am
”Certiorari stage documents:Opinion below (3d Cir.)Petition for certiorariBrief of respondents Mutual Pharmaceutical Company, Inc. et al. in oppositionAmicus brief of David B. [read post]
5 Mar 2012, 6:00 pm
©2012 Amaxx Risk Solutions, Inc. [read post]
15 Jan 2021, 1:48 pm
Bausch Health (formerly Valeant Pharmaceuticals) – In yet another case of accounting fraud, the SEC obtained a $45 million penalty from Bausch Health, formerly known as Valeant Pharmaceuticals, to resolve charges that its executives engaged in improper revenue recognition and misleading disclosures in SEC filings and earnings presentations. [read post]
1 Feb 2022, 12:32 am
Regele dated 16 January 2017D50 Assignment by the inventors to Alexion Pharmaceuticals Inc. dated 28.03.2007, 02.04.2007 and 11.09.2007 respectivelyD51 Document supporting the name change from "UDEC Pharmaceuticals,Inc. to "Alexion Pharmaceuticals Inc"D52 Declaration of S. [read post]
13 May 2021, 2:24 pm
A company issues false or misleading statements, the truth emerges, and the company’s stock price drops causing investor losses. [read post]
4 May 2020, 4:26 pm
Biotechnology and pharmaceutical companies devote substantial sums of money to research and development (“R&D”). [read post]
23 Mar 2020, 2:30 am
Halliburton Company v Chubb Bermuda Insurance Ltd (Formerly known as Ace Bermuda Insurance Ltd), heard 12-13 November 2019. [read post]
